[Treatment of metastasizing carcinoma of the uterus with gestagens].
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy; D008234:Lynestrenol / Q000627:therapeutic use; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011278:Pregnanes / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*; D011379:Prognosis; D014594:Uterine Neoplasms / Q000188:drug therapy*
D006908:Hydroxyprogesterones; D011278:Pregnanes; D011372:Progestins; D008525:Medroxyprogesterone; D008234:Lynestrenol
Gestagenbehandlung beim metastasierenden Korpuskarzinom.